Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-071467
Filing Date
2025-05-14
Accepted
2025-05-14 16:24:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5337
  Complete submission text file 0000950170-25-071467.txt   7099
Mailing Address 555 CALIFORNIA STREET 40TH FLOOR SAN FRANCISCO CA 94104
Business Address 555 CALIFORNIA STREET 40TH FLOOR SAN FRANCISCO CA 94104 4159811710
DODGE & COX (Filed by) CIK: 0000200217 (see all company filings)

EIN.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 0000

Mailing Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130
Business Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Subject) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-46089 | Film No.: 25946097
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)